奎斯特诊疗(DGX.N)今日盘中股价大涨5.1%,报收于144.26美元。引发该股价大涨的主因是该公司2024年第四季度业绩表现优异,超出市场预期。
根据财报显示,奎斯特诊疗第四季度营收同比增长14.6%至26.2亿美元,高于分析师预期的25.8亿美元;调整后每股收益2.23美元,也超出了分析师平均预期的2.19美元。值得一提的是,该公司全年营收预计在107亿至108.5亿美元之间,高于预期的106.7亿美元。
业绩超预期的主要原因是消费者对于诊断测试需求强劲。特别是在大流行后,越来越多人(尤其是老年人)进行各种检测,导致诊断业务需求持续旺盛。此外,该公司近期收购加拿大LifeLabs公司的步伐也进一步扩展了其在北美市场的影响力。对于2025年业绩前景,首席执行官吉姆-戴维斯表示充满信心,因公司将受益于医疗保健需求长期向好的趋势,以及收购带来的增长动能。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.